Clinical Trial

cfMSC Stem Cell Therapy Targeting COPD

Name: cfMSC Stem Cell Therapy Targeting COPD — clinical trial record (NCT07477600)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

Recruiting Phase 1/2

View on ClinicalTrials.gov →

Summary

The primary objectives are to evaluate the safety and efficacy of infusion of fully characterized clonally derived fetal mesenchymal stem cells (cfMSCs) for the control of severe symptoms associated with moderate to severe chronic obstructive pulmonary disease.

Protocol Amendment History 1 amendment

This ClinicalTrials.gov record has been amended once since 2026-03-12.

Trial Details

NCT Number	NCT07477600
Lead Sponsor	Shenzhen Geno-Immune Medical Institute
Conditions	Chronic Obstructive Pulmonary Disease (COPD)
Enrollment	30 participants
Start Date	2026-03-10
Primary Completion	2029-03-31 (estimated)
Study Completion	2030-04-30 (estimated)
Updated on ClinicalTrials.gov	2026-03-25